Skip to main content

Table 1 Demographics of patients with MDD who receive initial treatment with SSRI monotherapy

From: What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

Characteristic

Initial treatment with SSRI (N = 5,012)

Gender; n (%)

 

 Female

3,267 (65.2)

 Male

1,745 (34.8)

Age; mean (SD)

41.9 (15.3)

Age distribution in years; n (%)

 

 18–24

773 (15.4)

 25–34

948 (18.9)

 35–44

1,164 (23.2)

 45–54

1,110 (22.1)

 55–64

722 (14.4)

 65+

295 (5.9)

Plan type; n (%)

 

 CDHP

174 (3.5)

 COMP

224 (4.5)

 EPO

78 (1.6)

 HMO

1,233 (24.8)

 Non-capitated POS

449 (9.0)

 POS with capitation

9 (0.2)

 PPO

2,696 (54.3)

 Missing/unknown

99 (2.0)

Region; n (%)

 

 Northeast

718 (14.3)

 North central

1,324 (26.4)

 South

1,431 (28.6)

 West

1,526 (30.4)

 Unknown

13 (0.3)

Charlson comorbidity index; mean (SD), median

0.5 (1.1), 0.0

Chronic disease score; mean (SD), median

2.1 (2.5), 1.0

  1. CDHP consumer-driven health insurance, COMP comprehensive medical insurance, EPO exclusive provider organization, HMO health maintenance organization, POS point of service, PPO preferred provider organization.